Conditional Inactivation of p53 in Mouse Ovarian Surface Epithelium Does Not Alter MIS Driven Smad2-Dominant Negative Epithelium-Lined Inclusion Cysts or Teratomas

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Quartuccio, Suzanne M ^a   Lantvit, Daniel D ^a   Bosland, Maarten C ^a   Burdette, Joanna E ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; GENETIC TRANSCRIPTION; KERATINIZATION; MICROSATELLITE INSTABILITY; MORPHOLOGY; MOUSE; NONHUMAN; OLIGOMERIZATION; OVARY CARCINOMA; PHENOTYPE; POLYADENYLATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TERATOMA; TRANSGENE; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTI-MULLERIAN HORMONE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICE, TRANSGENIC; OVARIAN CYSTS; OVARIAN NEOPLASMS; OVARY; PHENOTYPE; SMAD2 PROTEIN; TERATOMA; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE; MUS; MUS MUSCULUS;

EID: 84878597923     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065067     Document Type: Article

References (45)

1. (2011) Cancer Facts and Figures. American Cancer Society.
2. Ness RB, Grisso JA, Cottreau C, Klapper J, Vergona R, et al. (2000) Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 11: 111-117.
3. Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, et al. (2001) Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195: 451-456.
4. Mittal KR, Zeleniuch-Jacquotte A, Cooper JL, Demopoulos RI, (1993) Contralateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions. International Journal of Gynecological Pathology 12: 59-63.
5. Feeley KM, Wells M, (2001) Precursor lesions of ovarian epithelial malignancy. Histopathology 38: 87-95.
6. Schlosshauer PW, Cohen CJ, Penault-Llorca F, Miranda CR, Bignon Y-J, et al. (2003) Prophylactic oophorectomy. Cancer 98: 2599-2606.
7. Cherchi PL, Capobianco G, Ambrosini G, Fadda GM, Piga MD, et al. (2002) Intracystic evaluation of tumor markers in benign and malignant ovarian pathology. European Journal of Gynaecological Oncology 23: 163-165.
8. Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, et al. (2007) A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 211: 26-35.
9. Levanon K, Ng V, Piao HY, Zhang Y, Chang MC, et al. (2010) Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 29: 1103-1113.
10. Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, et al. (2006) The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 30: 230-236.
11. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, et al. (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. American Journal of Surgical Pathology 31: 161-169.
12. Helleman J, Smid M, Jansen MPHM, van der Burg MEL, Berns EMJJ, (2010) Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: The big picture. Gynecologic Oncology 117: 170-176.
13. Carey MS, Agarwal R, Gilks B, Swenerton K, Kalloger S, et al. (2010) Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-Beta pathway signaling indicates response to primary chemotherapy. Clinical Cancer Research 16: 2852-2860.
14. Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-615.
15. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
16. Clark-Knowles KV, Senterman MK, Collins O, Vanderhyden BC, (2009) Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas. PLoS ONE 4: e8534.
17. Quinn BA, Brake T, Hua X, Baxter-Jones K, Litwin S, et al. (2009) Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca and p53. PLoS ONE 4: e8404.
18. Szabova L, Yin C, Bupp S, Guerin TM, Schlomer JJ, et al. (2012) Perturbation of Rb, p53 and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer. Cancer Res.
19. Moustakas A, Souchelnytskyi S, Heldin CH, (2001) Smad regulation in TGF-beta signal transduction. Journal of Cell Science 114: 4359-4369.
20. Bristol-Gould SK, Hutten CG, Sturgis C, Kilen SM, Mayo KE, et al. (2005) The development of a mouse model of ovarian endosalpingiosis. Endocrinology 146: 5228-5236.
21. Li J, Abushahin N, Pang S, Xiang L, Chambers SK, et al. (2011) Tubal origin of 'ovarian' low-grade serous carcinoma. Mod Pathol.
22. Burdette JE, Oliver RM, Ulyanov V, Kilen SM, Mayo KE, et al. (2007) Ovarian epithelial inclusion cysts in chronically superovulated CD1 and Smad2 dominant-negative mice. Endocrinology 148: 3595-3604.
23. Gamwell LF, Collins O, Vanderhyden BC, (2012) The mouse ovarian surface epithelium contains a population of LY6A (SCA-1) expressing progenitor cells that are regulated by ovulation-associated factors. Biology of Reproduction 87: 80.
24. Burdette JE, Jeruss JS, Kurley SJ, Lee EJ, Woodruff TK, (2005) Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells. Cancer Research 65: 7968-7975.
25. Toh MF, Sohn J, Chen SN, Yao P, Bolton JL, et al. (2012) Biological characterization of non-steroidal progestins from botanicals used for women's health. Steroids 77: 765-773.
26. Kruk PA, Maines-Bandiera SL, Auersperg N, (1990) A simplified method to culture human ovarian surface epithelium. Laboratory Investigation 63: 132-136.
27. King SM, Hilliard TS, Wu LY, Jaffe R, Fazleabas AT, et al. (2011) The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer. Endocrine-Related Cancer.
28. Jackson KS, Inoue K, Davis DA, Hilliard TS, Burdette JE, (2009) Three-dimensional ovarian organ culture as a tool to study normal ovarian surface epithelial wound repair. Endocrinology 150: 3921-3926.
29. Kumar TR, (2007) Multiple ovulations, ovarian epithelial inclusion cysts, and it'SMAD two! Endocrinology. 148: 3591-3594.
30. Clark-Knowles KV, Garson K, Jonkers J, Vanderhyden BC, (2007) Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes. Experimental Cell Research 313: 133-145.
31. Flesken-Nikitin A, Choi K-C, Eng JP, Shmidt EN, Nikitin AY, (2003) Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Research 63: 3459-3463.
32. Drapkin R, Crum CP, Hecht JL, (2004) Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia. Hum Pathol 35: 1014-1021.
33. Ahmed AA, Becker CM, Bast RC Jr, (2012) The origin of ovarian cancer. BJOG 119: 134-136.
34. Auersperg N, (2011) The origin of ovarian carcinomas: a unifying hypothesis. International Journal of Gynecological Pathology 30: 12-21.
35. Garson K, Gamwell LF, Pitre E, Vanderhyden BC, (2012) Technical challenges and limitations of current mouse models of ovarian cancer. J Ovarian Res 5: 39.
36. Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, et al. (2005) Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 11: 63-70.
37. Ghosh M, Schaefer TM, Fahey JV, Wright JA, Wira CR, (2008) Antiviral responses of human fallopian tube epithelial cells to toll-like receptor 3 agonist poly(I:C). Fertil Steril 89: 1497-1506.
38. Li QL, Agno JE, Edson MA, Nagaraja AK, Nagashima T, et al. (2011) Transforming growth factor beta receptor type 1 is essential for female reproductive tract integrity and function. Plos Genetics 7.
39. Feeley BT, Conduah AH, Sugiyama O, Krenek L, Chen IS, et al. (2006) In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models. J Orthop Res 24: 1709-1721.
40. Scully RE, (1987) Classification of human ovarian tumors. Environ Health Perspect 73: 15-25.
41. Sanghera P, El Modir A, Simon J, (2006) Malignant transformation within a dermoid cyst: a case report and literature review. Arch Gynecol Obstet 274: 178-180.
42. James D, Levine AJ, Besser D, Hemmati-Brivanlou A, (2005) TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132: 1273-1282.
43. Gordeeva OF, Nikonova TM, Lifantseva NV, (2009) [Regulation of in vitro and in vivo differentiation of mouse embryonic stem cells, embryonic germ cells, and teratocarcinoma cells by TGFb family signaling factors]. Ontogenez 40: 403-418.
44. Serrero G, Zhou J, Mills D, LePak N, (1991) Decreased transforming growth factor-beta response and binding in insulin-independent teratoma-derived cell lines with increased tumorigenic properties. Journal of Cellular Physiology 149: 503-511.
45. Sabol M, Car D, Musani V, Ozretic P, Oreskovic S, et al. (2012) The Hedgehog signaling pathway in ovarian teratoma is stimulated by Sonic Hedgehog which induces internalization of Patched. International Journal of Oncology.